NCT04969939: An ongoing trial by Novo Nordisk A/S
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 week, 2 days ago.
Full data
| Full entry on ClinicalTrials.gov | NCT04969939 |
|---|---|
| Title | Investigation of Efficacy and Safety of NNC0165-1875 as add-on to Semaglutide for Weight Management in Subjects With Obesity |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 15, 2021 |
| Completion date | Dec. 6, 2022 |
| Required reporting date | Dec. 6, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |